 Biomerica NASDAQ: BMRA is one of 30 public companies in the Diagnostic substances industry, but how does it compare to its competitors? We will compare Biomerica to related businesses based on the strength of its risk, institutional ownership, valuation, dividends, profitability, analyst recommendations and earnings. Valuation and Earnings This table compares Biomerica and its competitors ... 